Bayer AG's top pharmaceutical products based on revenue 2014-2018

Bayer AG is an international pharmaceutical and agriculture company. As of 2018, their top pharmaceutical product was Xarelto, a blood clot reducing medication used in the treatment of coronary artery disease. During that year Xarelto generated an estimated 3.6 billion U.S. dollars in revenues for Bayer. The second highest revenue generating pharmaceutical for Bayer was Eylea, which generated 2.2 billion U.S. dollars at that time.

Bayer’s company profile

Bayer is a German pharmaceutical and agriculture company with several segments such as Pharmaceuticals and Crop Science. Bayer operates on a global level. Bayer’s largest revenue-generating segment is their pharmaceutical segment, followed by their Crop Science segment. The company’s general revenue increases are reflected in the increases in revenue for Bayer HealthCare in recent years. Bayer is among the top pharmaceutical companies globally.

Global pharmaceuticals

The top pharmaceutical companies based on research and development expenses include big names such as Roche, Johnson & Johnson, and Novartis. These companies rely heavily on the research and development of new drugs. Currently the top pharmaceutical products globally include AbbVie’s Humira, Pfizer’s Eliquis. And Celgene’s Revlimid. The worldwide pharmaceutical market has been growing significantly in recent years and estimates suggest that there will be many new opportunities for these top companies to develop new drugs.

Bayer AG's top pharmaceutical products from 2014 to 2018, based on revenue

20142015201620172018
------
------
------
------
------
------
------
------
------
------
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2014 to 2018

Supplementary notes

This statistic was assembled from several editions of Bayer's annual report.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Bayer AG"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.